Latest news releases

View all

The “One World Protected” Event, hosted today by the United States and Gavi, the Vaccine Alliance, launched a campaign to raise US$ 2 billion for the global fight against COVID-19.

The COVAX Facility has now delivered life-saving vaccines to over 100 economies since making its first international delivery to Ghana on February 24th.

The partnership will focus on reaching children who are currently receiving no routine vaccines and marginalised communities in line with Gavi’s vision to ‘leave no-one behind with immunisation’.

The virtual event will bring together world leaders, the private sector, civil society, and key technical partners to galvanize resources and commitment to the Gavi COVAX Advance Market Commitment (AMC).

The COVAX Facility has notified participating economies that deliveries of doses from the Serum Institute of India (SII) will be delayed in March and April.

Latest publications

View all

15 December 2020

Cold chain equipment technology guide

This document is designed to guide country applications for cold chain equipment (CCE) support, providing a structured approach to CCE purchasing decisions. It helps identify which devices comply with the requirements of Gavi's cold chain equipment platform, allowing countries to choose solutions that best meet the needs of their health facilities.

8 October 2020

Geographic information systems and immunisation landscape

Exploring current approaches to leaving no child behind with immunisation by harnessing geospatial technologies and GIS to improve immunisation coverage and equity in low- and middle-income countries.

Gavi for the media

Visit our dedicated media room to see our latest press releases and statements, updated key facts and figures, as well as contact details for our media team.

Visit media room

Visit our dedicated media room to see our latest press releases and statements, updated key facts and figures, as well as contact details for our media team.

Visit media room
Last updated: 14 Apr 2021

Subscribe to our newsletter